AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12494285 — intervention group
Group type: COMPARATOR
Intervention: Needle-tipped injection
Number of subjects: 8
Study 9819795 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1: Cytosine arabinoside (Ara‐C) (100 mg/m2/d, days 1‐7) and idarubicin (Ida) (12 mg/m2/d, days 1‐3) for induction; Ara‐C (200 mg/m2/d, days 1‐6) and Ida (15 mg/m2/d, day 1) twice for consolidation.
Number of subjects: 99
Study 9819795 — intervention group
Group type: COMPARATOR
Intervention: Group 2: Ara‐C (200 mg/m2/d, days 1‐10), daunorubicin (Dnc) (50 mg/m2/d, days 1, 3, 5) and etoposide (VP16) (100 mg/m2/d, days 1‐5) for induction; consolidation therapy with Ara‐C on days 1‐8 and additional regimens.
Number of subjects: 99
Study 9819795 — intervention group
Group type: COMPARATOR
Intervention: Group 3: Identical to Group 1 except for Ida replaced with Mitox.
Number of subjects: 99
Study 8086025 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 ml of 0.5% bupivacaine
Number of subjects: 48
Study 8086025 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 48
Study 2756086 — intervention group
Group type: EXPERIMENTAL
Intervention: High stress condition (Type A students)
Number of subjects: 99
Study 2756086 — intervention group
Group type: COMPARATOR
Intervention: Low stress condition (Type A students)
Number of subjects: 99
Study 2756086 — intervention group
Group type: EXPERIMENTAL
Intervention: High stress condition (Type A community women)
Number of subjects: 99
Study 2756086 — intervention group
Group type: COMPARATOR
Intervention: Low stress condition (Type A community women)
Number of subjects: 99
Study 331941 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple dye
Number of subjects: 3
Study 331941 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver sulfadiazine
Number of subjects: 3
Study 331941 — intervention group
Group type: COMPARATOR
Intervention: Castile soap
Number of subjects: 3
Study 30690854 — intervention group
Group type: EXPERIMENTAL
Intervention: NA-STEMI patients undergoing PCI
Number of subjects: 1495
Study 30690854 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors for NA-STEMI patients
Number of subjects: 1495
Study 29175466 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) with 0.01% Methylene Blue and red laser, λ660 nm, 3J energy per point
Number of subjects: 29
Study 29175466 — intervention group
Group type: COMPARATOR
Intervention: Low level laser therapy (LLLT) with λ660 nm, 1J energy per point
Number of subjects: 29
Study 29175466 — intervention group
Group type: EXPERIMENTAL
Intervention: Both PDT and LLLT
Number of subjects: 29
Study 26966058 — intervention group
Group type: EXPERIMENTAL
Intervention: Tianjiu therapy applied at three points (conception vessel 4, and bilateral kidney 1) during each HD session for 4 weeks.
Number of subjects: 0
Study 26966058 — intervention group
Group type: COMPARATOR
Intervention: Clay patches applied in the same way as those in the Tianjiu treatment group for 4 weeks.
Number of subjects: 0
Study 26966058 — intervention group
Group type: EXPERIMENTAL
Intervention: Tianjiu therapy
Number of subjects: 0
Study 26966058 — intervention group
Group type: COMPARATOR
Intervention: Clay patches
Number of subjects: 0
Study 24388635 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezosurgery
Number of subjects: 59
Study 24388635 — intervention group
Group type: COMPARATOR
Intervention: Lindeman bur and chisel (Control)
Number of subjects: 59
Study 21827501 — intervention group
Group type: EXPERIMENTAL
Intervention: Single Target Implicit Association Test (ST-IAT) - Image version
Number of subjects: 253
Study 21827501 — intervention group
Group type: EXPERIMENTAL
Intervention: Single Target Implicit Association Test (ST-IAT) - Word version
Number of subjects: 253
Study 21827501 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-report measures of blood donation attitudes
Number of subjects: 253
Study 21827501 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-report measures of blood and needle fears
Number of subjects: 253
Study 19926782 — intervention group
Group type: EXPERIMENTAL
Intervention: rosiglitazone (4 mg/day for 6 weeks followed by 8 mg/day for 6 weeks)
Number of subjects: 23
Study 19926782 — intervention group
Group type: EXPERIMENTAL
Intervention: rosiglitazone
Number of subjects: 23
Study 17351377 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 53
Study 17351377 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 53
Study 15846970 — intervention group
Group type: EXPERIMENTAL
Intervention: Claims-driven decision support system
Number of subjects: 0
Study 11846190 — intervention group
Group type: EXPERIMENTAL
Intervention: Meloxicam 7.5 mg
Number of subjects: 22
Study 11846190 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 9972764 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure palpator
Number of subjects: 50
Study 9972764 — intervention group
Group type: COMPARATOR
Intervention: Pinprick
Number of subjects: 50
Study 7562885 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin 10 mg for 1 month, 20 mg for 1 month, 40 mg for 4 months (once daily in the evening)
Number of subjects: 50
Study 7562885 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 25)
Number of subjects: 50
Study 2196107 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy with methotrexate, cisplatin, and continuous infusion 5-fluorouracil (MPF) (arm A)
Number of subjects: 42
Study 2196107 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy with bleomycin, cisplatin, and methotrexate (PBM) alternating with cisplatin and 5-FU (PF) (arm B)
Number of subjects: 42
Study 322269 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen
Number of subjects: 12
Study 322269 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen
Number of subjects: 12
Study 322269 — intervention group
Group type: COMPARATOR
Intervention: Control period
Number of subjects: 12
Study 322269 — intervention group
Group type: COMPARATOR
Intervention: Comparison between Ketoprofen and Naproxen
Number of subjects: 12
Study 31393397 — intervention group
Group type: EXPERIMENTAL
Intervention: Thread Embedding Acupuncture (TEA)
Number of subjects: 128
Study 31393397 — intervention group
Group type: COMPARATOR
Intervention: Physical Therapy (PT)
Number of subjects: 128
Study 31393397 — intervention group
Group type: EXPERIMENTAL
Intervention: TEA
Number of subjects: 128
Study 31393397 — intervention group
Group type: COMPARATOR
Intervention: PT
Number of subjects: 128
Study 29085049 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftiofur crystalline‐free acid (CCFA)
Number of subjects: 176
Study 29085049 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlortetracycline
Number of subjects: 176
Study 29085049 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment specified)
Number of subjects: 176
Study 24898613 — intervention group
Group type: EXPERIMENTAL
Intervention: $10 gift cards after mental health visits
Number of subjects: 42
Study 24898613 — intervention group
Group type: COMPARATOR
Intervention: No financial incentives (control group)
Number of subjects: 42
Study 23786763 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (ICBT) with MoodGYM
Number of subjects: 14
Study 21303218 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard protocol of aerobic physical activity: 150 min of moderate intensity aerobic activity per week
Number of subjects: 50
Study 21303218 — intervention group
Group type: COMPARATOR
Intervention: Control group (20 patients with vascular ED who did not undergo aerobic physical activity)
Number of subjects: 50
Study 19809326 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone (150 mg)
Number of subjects: 120
Study 19809326 — intervention group
Group type: COMPARATOR
Intervention: Control (Isotonic saline)
Number of subjects: 120
Study 19809326 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (100 mg)
Number of subjects: 120
Study 16470128 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 or 80 mg/day
Number of subjects: 0
Study 16470128 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 15195758 — intervention group
Group type: EXPERIMENTAL
Intervention: Extensive BMV hemispheres
Number of subjects: 16
Study 15195758 — intervention group
Group type: EXPERIMENTAL
Intervention: Diminished BMV hemispheres
Number of subjects: 16
Study 15195758 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 16
Study 11131620 — intervention group
Group type: EXPERIMENTAL
Intervention: Horizontally oriented histograms
Number of subjects: 0
Study 11131620 — intervention group
Group type: COMPARATOR
Intervention: Vertically oriented histograms
Number of subjects: 0
Study 11131620 — intervention group
Group type: COMPARATOR
Intervention: Pie charts
Number of subjects: 0
Study 9321533 — intervention group
Group type: EXPERIMENTAL
Intervention: Enforcement of tobacco-sales laws in three communities (intervention group)
Number of subjects: 22021
Study 9321533 — intervention group
Group type: COMPARATOR
Intervention: No enforcement of tobacco-sales laws in three matched communities (control group)
Number of subjects: 22021
Study 8423275 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal beclomethasone dipropionate
Number of subjects: 21
Study 8423275 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 3528223 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg folic acid daily
Number of subjects: 3
Study 3528223 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study 29722833 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA-rich fish oil (2.3 g daily)
Number of subjects: 403
Study 29722833 — intervention group
Group type: COMPARATOR
Intervention: Placebo (low-polyphenolic olive oil)
Number of subjects: 403
Study 27168163 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% phenoxyethanol
Number of subjects: 243
Study 27168163 — intervention group
Group type: COMPARATOR
Intervention: TRPV1 antagonist ID1609
Number of subjects: 243
Study 26387418 — intervention group
Group type: EXPERIMENTAL
Intervention: Thai massage applied on the lower back and lower limbs for 30 minutes.
Number of subjects: 17
Study 22524327 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Widman flap surgery with diode laser (810 nm)
Number of subjects: 13
Study 22524327 — intervention group
Group type: COMPARATOR
Intervention: Modified Widman flap surgery alone
Number of subjects: 13
Study 21426752 — intervention group
Group type: EXPERIMENTAL
Intervention: Stenotic microvasculopathy
Number of subjects: 64
Study 18202561 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological skills training (PST)
Number of subjects: 18
Study 18202561 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 18
Study 17628127 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodic health evaluation (PHE)
Number of subjects: 36
Study 17628127 — intervention group
Group type: EXPERIMENTAL
Intervention: Scheduling of appointments for PHE
Number of subjects: 36
Study 17628127 — intervention group
Group type: EXPERIMENTAL
Intervention: Offering a free PHE
Number of subjects: 36
Study 15580719 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial based pacing
Number of subjects: 73
Study 15580719 — intervention group
Group type: COMPARATOR
Intervention: VVI(R) pacing
Number of subjects: 73
Study 10674597 — intervention group
Group type: COMPARATOR
Intervention: Formula company-produced materials (commercial; n = 277)
Number of subjects: 547
Study 9114206 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulbactam/cefoperazone (2-4 g/d) administered in evenly divided doses every 12 hours by a 30-minute intravenous drip
Number of subjects: 235
Study 9114206 — intervention group
Group type: COMPARATOR
Intervention: Cefotaxime (6-12 g/d) administered in evenly divided doses every 6 or 8 hours by a 30-minute intravenous drip
Number of subjects: 235
Study 8404241 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 0
Study 8404241 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3513083 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunarizine
Number of subjects: 50
Study 3513083 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 30281805 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral oestradiol (2 mg/d)
Number of subjects: 40
Study 30281805 — intervention group
Group type: COMPARATOR
Intervention: Transdermal oestradiol (100 µg/d)
Number of subjects: 40
Study 30195946 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine 0.25%
Number of subjects: 68
Study 30195946 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxymetazoline 0.05%
Number of subjects: 68
Study 30195946 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 1% with epinephrine 1:100,000
Number of subjects: 68
Study 30195946 — intervention group
Group type: COMPARATOR
Intervention: Saline (bacteriostatic 0.9% sodium chloride)
Number of subjects: 68
Study 27765686 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% sucralfate ointment (every 12 hours)
Number of subjects: 41
Study 27765686 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 23205666 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive vascular risk factor intervention
Number of subjects: 195
Study 23205666 — intervention group
Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 195
Study 22741944 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone induction in primary care (n = 147)
Number of subjects: 195
Study 22741944 — intervention group
Group type: COMPARATOR
Intervention: Methadone induction in CSAPA (n = 48)
Number of subjects: 195
Study 20049522 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-woven textile material (modified tampon) for vaginal drug delivery
Number of subjects: 47
Study 18652727 — intervention group
Group type: EXPERIMENTAL
Intervention: Waiting room video
Number of subjects: 1132
Study 15798411 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lidocaine gel
Number of subjects: 91
Study 15798411 — intervention group
Group type: COMPARATOR
Intervention: Plain lubricant
Number of subjects: 91
Study 12453372 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin (Group 1)
Number of subjects: 125
Study 12453372 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin or clarithromycin (Group 2)
Number of subjects: 125
Study 11188778 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIG (intravenous immunoglobulin) 0.15-0.2 g/kg bodyweight monthly for 2 years
Number of subjects: 148
Study 9093096 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening for breast cancer (mammography)
Number of subjects: 158755
Study 9093096 — intervention group
Group type: COMPARATOR
Intervention: Control group (not invited to screening)
Number of subjects: 158755
Study 9093096 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening for breast cancer (mammography) among women aged under 56 years
Number of subjects: 158755
Study 8244414 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 cm handle span
Number of subjects: 18
Study 8244414 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 cm handle span
Number of subjects: 18
Study 8244414 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended trigger
Number of subjects: 18
Study 8244414 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing handle span from 4 cm to 7 cm
Number of subjects: 18
Study 8244414 — intervention group
Group type: EXPERIMENTAL
Intervention: Handle span preference
Number of subjects: 18
Study 3326525 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole 400 mg
Number of subjects: 160
Study 3326525 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole 800 mg
Number of subjects: 160
Study 3326525 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole 1200 mg
Number of subjects: 160
Study 3326525 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole 1600 mg
Number of subjects: 160
Study 3326525 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole (various doses)
Number of subjects: 160
Study 31711306 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental therapy (50% efficacious)
Number of subjects: 0
Study 31711306 — intervention group
Group type: COMPARATOR
Intervention: Control therapy (80% efficacious)
Number of subjects: 0
Study 31711306 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed enrollment strategy (TST and IGRA)
Number of subjects: 0
Study 29659178 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg of botanically sourced caffeine from 480 mg of green coffee bean extract
Number of subjects: 16
Study 29659178 — intervention group
Group type: COMPARATOR
Intervention: 60 mg of synthetic USP caffeine
Number of subjects: 16
Study 27999162 — intervention group
Group type: EXPERIMENTAL
Intervention: Heterologous fecal microbiota transplantation (FMT)
Number of subjects: 0
Study 27999162 — intervention group
Group type: COMPARATOR
Intervention: Autologous fecal microbiota transplantation (FMT)
Number of subjects: 0
Study 27999162 — intervention group
Group type: EXPERIMENTAL
Intervention: Heterologous FMT
Number of subjects: 0
Study 27999162 — intervention group
Group type: COMPARATOR
Intervention: Autologous FMT
Number of subjects: 0
Study 24930044 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary autologous bone marrow stem cell (mBMC) transplantation
Number of subjects: 30
Study 24930044 — intervention group
Group type: COMPARATOR
Intervention: Patients with AMI
Number of subjects: 30
Study 24930044 — intervention group
Group type: COMPARATOR
Intervention: Patients with stable angina pectoris (AP)
Number of subjects: 30
Study 22840731 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (hip extensor fatigue)
Number of subjects: 40
Study 22840731 — intervention group
Group type: COMPARATOR
Intervention: Sham control group (push-ups to exhaustion)
Number of subjects: 40
Study 20096510 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended cognitive behavioral treatment
Number of subjects: 199
Study 20096510 — intervention group
Group type: COMPARATOR
Intervention: Standard Treatment
Number of subjects: 199
Study 18724004 — intervention group
Group type: EXPERIMENTAL
Intervention: Dried-bonito broth
Number of subjects: 159
Study 16050395 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional hemodialysis (three sessions per week through a low‐flux membrane)
Number of subjects: 0
Study 16050395 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal dialysis strategies (not specified)
Number of subjects: 0
Study 12878335 — intervention group
Group type: COMPARATOR
Intervention: Usual nutritional rehabilitation program
Number of subjects: 165
Study 12878335 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual nutritional rehabilitation program + 5 g x d(‐1) of spiruline
Number of subjects: 165
Study 12878335 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual nutritional rehabilitation program + spiruline + fish
Number of subjects: 165
Study 10376262 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg midazolam
Number of subjects: 55
Study 10376262 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 8888911 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant formula with higher TRP content (2.10%)
Number of subjects: 20
Study 8888911 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant formula with moderate TRP content (1.88%)
Number of subjects: 20
Study 8888911 — intervention group
Group type: COMPARATOR
Intervention: Breastfed control group (11 infants)
Number of subjects: 20
Study 1858500 — intervention group
Group type: EXPERIMENTAL
Intervention: Topically applied vaginal tablet of 150 mg econazole
Number of subjects: 235
Study 1858500 — intervention group
Group type: COMPARATOR
Intervention: Orally administered capsule of 150 mg fluconazole
Number of subjects: 235
Study 31152288 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness Based Cognitive Therapy (MBCT)
Number of subjects: 76
Study 31152288 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive Psychotherapy (PPT)
Number of subjects: 76
Study 31152288 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy (DBT)
Number of subjects: 76
Study 31152288 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 76
Study 27548791 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear periodized strength training (ST) program
Number of subjects: 31
Study 27548791 — intervention group
Group type: COMPARATOR
Intervention: Control group (no strength training)
Number of subjects: 31
Study 26005814 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training program of high intensity and low volume for 12 weeks
Number of subjects: 40
Study 26005814 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 40
Study 23218945 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonoscopy
Number of subjects: 4539
Study 21235716 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil for 12 weeks
Number of subjects: 115
Study 21235716 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 115
Study 19942723 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 119
Study 19942723 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid
Number of subjects: 119
Study 19942723 — intervention group
Group type: COMPARATOR
Intervention: Control (conventional expectant treatment)
Number of subjects: 119
Study 17279843 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal priming with negative affect coactivation
Number of subjects: 0
Study 17279843 — intervention group
Group type: COMPARATOR
Intervention: Goal priming without negative affect
Number of subjects: 0
Study 15036798 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine plus chloroquine (CsA/Clq)
Number of subjects: 149
Study 15036798 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine plus placebo (CsA/Plac)
Number of subjects: 149
Study 11277160 — intervention group
Group type: EXPERIMENTAL
Intervention: Training and implementation of evidence-based clinical practice guideline for neonatal skin care
Number of subjects: 2820
Study 11277160 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of project-designed tools and guidelines
Number of subjects: 2820
Study 11277160 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline implementation
Number of subjects: 2820
Study 9834926 — intervention group
Group type: EXPERIMENTAL
Intervention: High-complex-carbohydrate, low-fat formulation (HCF)
Number of subjects: 52